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Background: Recently, evidence indicated that the rapamycin-eluting stent which was used worldwide may
contribute to an increased risk for thrombosis. On the contrary, other researchers found it was safe. Thus, it is
necessary to clarify the effect of rapamycin on thrombosis and the corresponding mechanisms.
Results: The effects of rapamycin in vivo were evaluated by modified deep vein thrombosis animal model. The
platelets were from healthy volunteers and the platelet-endothelium (purchased from ATCC) adhesion in cultured
endothelial cells was assessed. Membrane rufflings in endothelial cells were examined by confocal and electron
microscope. Thrombus formation increased in rats that were injected with rapamycin. Electron microscope analysis
exhibited microvilli on the rapamycin-treated endothelium in rats. Rapamycin enhanced membrane ruffling in
human umbilical vein endothelial cells (HUVECs) and adhesion of platelets to HUVECs. The platelet-HUVECs
adhesion was attenuated when cells were treated with cytochalacin B. Inhibition of autophagy by 3-methyladenine
led to suppression of membrane ruffles in HUVECs and augmentation of platelet-endothelial adhesion.
Conclusions: In conclusion, we found that endothelial membrane remodeling induced by rapamycin is crucial for
the adhesion of platelets to endothelial cells and thereby for thrombosis in vivo, and that the endothelial
membrane remodeling is autophagy dependent.
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Venous thrombosis, including deep vein thrombosis
(DVT) and pulmonary embolism, is a major source of
morbidity and mortality worldwide [1]. Although it is ac-
cepted that the combination of so-called virchow triad,
namely 1) vascular abnormalities and endothelial dysfunc-
tion, 2) hypercoagulability and 3) stasis, may play a pivotal
role in the pathogenesis of venous thrombosis, the under-
lying mechanisms are not fully elucidated.
The pathogenesis of thrombosis involves a variety of
factors among which platelet adhesion to endothelial
cells is one element of importance [2,3]. The data that* Correspondence: pingjiang@bjmu.edu.cn; caijp61@vip.sina.com
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reproduction in any medium, provided the oradhesion can occur in the mice who lack fibrinogen and
VWF suggests that some pivotal mechanisms, for ex-
ample, the platelet-endothelial interaction, may be in-
volved in this process and the concomitant thrombosis
[4]. We have known that the rougher the membrane sur-
faces are, the more the platelets adhere and the poorer the
hemocompatibility is, and vice versa [5]. The above data
suggested that the dynamic regulation of endothelial
membrane shape may affect the process of platelet adhe-
sion. In fact, the morphology of endothelial membrane
changed with environment frequently. For example, when
the transmural pressure elevated or cells were exposed to
E2, projections, such as membrane ruffles, pseudopodia
and microvilli, will appear on the outer surface of endo-
thelium and stretch into the vessel lumen [6,7].
Kadandale et al. [8] identified that autophagy plays a
pivotal role in blood cell cortical remodeling, withtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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lamellipodia and filopodia. Rapamycin is a kind of autoph-
agy agonist, which was reported to be associated with
regulation of endothelial cytoskeleton [9]. Every year,
rapamycin-eluting stents are implanted in millions of pa-
tients with coronary artery disease who undergo percutan-
eous coronary intervention. However, evidence indicated
that rapamycin-eluting stents may be associated with an
increased risk for stent thrombosis when compared with
bare-metal stents [4,10]. For example, Camici et al. [10]
reported that rapamycin promoted arterial thrombosis in
vivo. In endothelial cells, rapamycin can enhance the activ-
ity of tissue factor (TF) which is a key trigger of coagula-
tion cascade. In addition, the effects that rapamycin
inhibits tissue plasminogen activator (t-PA) and induces
plasminogen activator inhibitor 1 (PAI-1) in human um-
bilical vein endothelial cells (HUVECs) may contribute to
thrombosis associated with rapamycin-eluting stents [11].
On the contrary, Daemen et al. and others [12,13] found
that rapamycin-eluting stents were safe and effective com-
pared with bare-metal ones. Thus, it is necessary to eluci-
date the effect of rapamycin on thrombosis.
In this study, we found that rapamycin (500 ng/kg)
promoted formation of microvilli-like structure in endo-
thelium and thrombotic occlusion in the modified DVT
rat model. HUVECs treated with rapamycin demon-
strated that both dorsal ruffling and platelets-endothelial
adhesion were promoted. Suppressing dorsal ruffling by
cytochalasin B led to inhibited platelet-endothelial adhe-
sion. Further analysis suggested that rapamycin-mediated
autophagy activation may contribute to the formation of
the dorsal ruffling in endothelial cells.
Results
Rapamycin promoted thrombus formation in vivo
To clarify the effect of rapamycin on thrombosis, modified
DVT rat model was adopted in this study (Figure 1A).
Rapamycin (500 ng/kg) or DMSO (control) was injected
into iliac vein as shown in Figure 1A when the IVC was
tied with silk suture. The vein is darkred before the forma-
tion of thrombotic occlusion. After the occlusion devel-
oped the veins became black and purple. Thrombosis was
confirmed by histological observation. The appearance of
an occlusive thrombus was clearly visible through the
microscope in the lumen of the vessels. The time-course
of effects of rapamycin on thrombotic occlusion was
shown in Additional file 1: Figure S1. At the time of the
40th minute, thrombotic occlusion developed in 20% of
the DMSO-injected rats and 80% of the rapamycin rats
(Figure 1B, P < 0.05). Hematoxylin and eosin staining of
the venous cross section showed that the thrombus oc-
cluded in the enlarged venous lumen of rapamycin-treated
rats (Figure 1C). A lot of platelet-derived clots were found
to speckle in the red thrombus or attach to the vascularintima (Figure 1C, the enlarged image in the lower
panel). Of note, large amount of microvilli-like struc-
tures (Figure 1D, indicated by arrow) appeared on the
surface of the endothelial membrane in rapamycin-
treated rats. By contrast, the endothelial membrane treated
with DMSO was smooth as shown by the ultrastructure of
the venous endothelium (Figure 1D). Microvilli-like struc-
ture was not obviously observed in the 20% of DMSO-
injected rats with positive thrombotic occlusion and rats
that were negative for thrombotic occlusions with 20% of
rapamycin injection.
Rapamycin enhanced platelet adhesion to endothelium
Recently, Iba et al. reported that adhesion of leukocytes to
endothelium was the first event initiating thrombus forma-
tion [11-14]. We have known that rough membranes can
enhance platelet adhesion. Thus we want to know whether
rapamycin can promote platelet-endothelial adhesion. First,
the time course of platelet-endothelium adhesion was eval-
uated as shown in Figure 2A. The amount of endothelium
with platelet adhered increases with time. The maximum-
adhesion point appears at the 30th minute and reaches its
plateau. DMSO-treated platelets-endothelium adhesion was
also assessed (Additional file 1: Figure S1A). Thus in the
following experiments we chose the 30th minute as the
time point. Then HUVECs were incubated with platelets,
together with rapamycin (10 nM) or DMSO treatment for
30 minutes. The platelet-endothelial adhesion was evalu-
ated. Results showed that rapamycin enhanced adhesion
activity between HUVECs and platelets. The quantity of
HUVECs with platelets adhered increased by 115% in
rapamycin treated group compared with that in DMSO
(Figure 2B and 2C, P < 0.05).
Rapamycin induced membrane remodeling in endothelium
As we have found, rapamycin induced microvilli-like
structure in the endothelial cells of mice. To have an
insight into the effect of rapamycin on the cultured
endothelial cells, HUVECs treated with rapamycin were
investigated by confocal microscopy. When HMVECs
were exposed to 10 nM of rapamycin, peripheral and
dorsal ruffles were found to arise from peripheral and
central of the surface (Figure 3A, lower panel) by detec-
tion of F-actin organization. By comparison, central ruf-
fles were observed little in the control (Figure 3A, upper
panel). Then HUVECs treated with different concentra-
tion of rapamycin were examined at different time
points by the way of immunofluorescence detection to
quantify membrane remodeling induced by rapamycin.
As shown in Figure 3B and 3C, rapamycin at the con-
centration of 10 to 1000 nM can lead to dramatically en-
hanced dorsal ruffle formation. And the formation of
prominent dorsal ruffles peaks at the 30th minute after
rapamycin stimulation.
Figure 1 Rapamycin promoted thrombosis in rats. (A) The diagram of the DVT rat model illustrated that the iliac vein which was tied at site
A was injected with rapamycin or DMSO and then tied tightly at the sites of a and b. (B) The ratio of thrombosis in rapamycin group (80%) is far
more than that in DMSO (20%) group. n = 10 in each group. (C) HE staining exhibited thrombosis in the venous lumen at the time of the 40th
minute. Enlarged squares indicate the platelet-derived clot appeared in the thrombus. (D) Transmission electron microscope analysis exhibited
microvilli-like structure on endothelial of rapamycin treated rats compared with the smooth endothelial surface in the DMSO treated rats
(TEM × 10, 000).
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platelet-endothelium adhesion
To show where platelet is going to interact with endothe-
lium, we added the platelets to the cultured endothelium.
As was shown in Additional file 1: Figure S1C, platelets
are apt to associate with endothelial cells at the site of ruf-
fles and filopodialike protrusions of the latter. Then cyto-
chalasin B, a drug that can bind to actin filaments and
block polymerization and elongation of actin, was added
to inhibit the formation of dorsal ruffle in order to explore
the effect of the ruffles on platelet-endothelial adhesion[15]. As shown in Figure 4A, HUVECs exhibited reduced
dorsal ruffles when incubated with 30 μM cytochalasin B
for 20 minutes even under the stimulation of rapamycin.
Platelet adhesion was inhibited after the HUVECs were
treated with cytochalasin B (Figure 4B). Compared with
the control (DMSO treatment), the platelet-endothelium
adhesion increased by 120% and 50% respectively, in rapa-
mycin incubated group and rapamycin + cytochalasin B
group. These data indicated that the dorsal ruffle forma-
tion of HUVECs is essential for the adhesion activity be-
tween platelets and endothelium.
Figure 2 Rapamycin induced platelets-endothelial adhesion. HUVECs were cultured on the gelatin-coated coverslips. Freshly isolated platelets
were added to the coverslip and incubated for the indicated time. Cells were fixed and stained with crystal violet. The coverslips were mounted
and imaged by microscopy. (A) The time course of platelet-endothelial adhesion exhibited that the platelets-endothelial adhesion reached its
plateau at the 30th minute. Columns, means of three independent experiments; bars, SD. (B) The upper and middle panel indicated that platelets
were seen adhering on the HUVECs. (C) HUVECs with platelets adhered were calculated and significant difference existed between the two
groups (P < 0.05). Columns, means of three independent experiments; bars, SD.
Figure 3 Rapamycin promoted membrane remodeling in HUVECs. (A) HUVECs were incubated with rapamycin (10 nM) for 30 minutes. Cells
were fixed and detected by immunofluorescence with an anti-β-actin antibody. The representative images showed the formation of dorsal ruffle.
(B) HUVECs were treated with the indicated concentration of rapamycin for 30 minutes. Cells were fixed and detected by immunofluorescence
with an anti-β-actin antibody. The ratio of cells with dorsal ruffle to total cells was evaluated. Notice that rapamycin at the concentration of 10 to
1000 nM can lead to dramatically enhanced dorsal ruffle formation. Columns, means of three independent experiments; bars, SD. (C) HUVECs were
incubated with rapamycin (10 nM) for the indicated time. Cells were fixed and detected by immunofluorescence with an anti-β-actin antibody.
The ratio of cells with dorsal ruffle to total cells was evaluated. Means ± SD are given and were obtained from 3 independent experiments.
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Figure 4 The membrane remodeling is essential for platelet-endothelial adhesion. HUVECs were treated with the indicated reagents. Cells
were fixed and detected by immunofluorescence with an anti-β-actin antibody. (A) The dorsal ruffle was indicated by arrows. (B) The ratio of cells
with dorsal ruffle to total cells was evaluated. The data showed that Cytochalasin B attenuated platelets-endothelial adhesion which was induced
by rapamycin. Means ± SD are given and were obtained from 3 independent experiments.
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Recently, it was reported that autophagy was essential for
the cortical remodeling of Drosophila blood cells (hemo-
cytes) and mouse macrophages. In this study, autophagic
activity of HUVECs was assessed by electron microscopy
and immunohistochemistry to investigate the effect of
rapamycin, one of the autophagy agonists. As expected,
autophagosomes, which were characterized by double-
membraned vesicles that contain cytosol or morphologic-
ally intact cytoplasmic organelles, could be observed in
the endothelium of rapamycin treated rats (Figure 5A, en-
larged square in lower panel). In contrast, autophagic ac-
tivity did not increase in the DMSO treated endothelium.
Immunohistochemical analysis showed that the intensity
of LC3-II, which is one of the markers indicating autopha-
gic activity, was stronger in endothelial cells treated with
rapamycin than DMSO (data not shown). Next, autopha-
gic activity induced by rapamycin was examined in the
cultured HUVECs. As could be seen in Figure 5B, rapamy-
cin incubation leads to aggregated fluorescent dots in the
HUVECs. In parallel, the ratio of LC3-II/LC3-I, which was
used as the marker of autophagy [16], of the rapamycin
group is higher than the DMSO group (Figure 5C). To ex-
plore the importance of rapamycin-mediating autophagic
activation to endothelial dorsal ruffling, we chose 3-MA,
which can block autophagosome formation via inhibition
of type III phosphatidylinositol 3-kinases, as the autophagy
inhibitor. 3-MA (5 nM) inhibits dorsal rufflings formation
induced by rapamycin by 67% as shown in Figure 5D. In
addition, starvation, which is a classic autophagy inducing
factor, enhanced the formation of membrane ruffle in the
HUVECs (data not shown). These data suggested that the
autophagic activity induced by rapamycin is responsible
for the formation of dorsal ruffle in HUVECs.Methods
Reagents
Anti-LC3-II antibody and anti-mouse IgG-FITC antibody
were obtained from Medical & Biological Laboratoris CO.,
LTD (#025, #107). Rapamycin, 3-methyladenine, and Cy-
tochalasin B were purchased from Sigma (#R878, #M9281,
C6762). Rhodamine labeled Goat anti-Rabbit IgG antibody
was from Kirkegaard & Perry Laboratories, Inc. (#110144).
Cell culture and preparation of washed human platelet
suspensions
HUVECs were purchased from ATCC and cultured in
Endothelial cell medium (containing 10% FBS, 1% ECGS,
and 1% penicillin/streptomycin solution) under a 5% CO2/
95% air atmosphere in a humidified incubator at 37°C.
Cells were used between passages 3 and 10.
Venous blood was drawn from healthy volunteers.
Platelet-rich plasma (PRP) was prepared by centrifuga-
tion at 500 g for 15 minutes at room temperature, and
then platelets were pelleted by centrifugation of the
PRP for 6 minutes at 2000 g and washed in HEPES buf-
fer warmed to 37°C (0.137 M NaCl, 2.68 mM KCl,
1 mM MgCl2, 1 mM CaCl2, 5 mM HEPES, and 0.1%
glucose, pH 6.8).
The work was approved by the Ethics Committee of the
National Center for Clinical Laboratories, and adhered to
the tenets of the Declaration of Helsinki. Written informed
consents were obtained from the donors.
Platelet adhesion assay
The platelet adhesion assay was performed as previ-
ously described [17] by some modification. In brief,
HUVECs were seeded on a gelatin coated coverslips at
a concentration of 5 × 105/ml and grown to confluence.
Figure 5 The membrane remodeling was induced by autophagy. (A) Transmission electron microscope analysis exhibited the induction of
autophagy in the venous endothelium. Enlarged square showed the autophagosome (TEM × 10, 000). (B, C) HUVECs were treated with the
indicated reagents, followed by fixation and detection by immunofluorescence (B) and western blot (C) with anti-LC3-II antibody. The representative
images indicated the dot-like structure of autophagosomes in the cells (B) and the expression of LC3-II in cells (C). Means ± SD are given and were
obtained from 4 independent experiments. (D), HUVECs were treated with the indicated reagents, and the formation of dorsal ruffle was analyzed. The
data exhibited that rapamycin induced dorsal ruffling. While 3-MA can suppress the formation of dorsal ruffle which was promoted by rapamycin.
Means ± SD are given and were obtained from 3 independent experiments.
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erslips and incubated for 20 minutes under vibrating at
37°C. Non-adhered platelets were removed by washing
with PBS. Cells were fixed in 3.7% paraformaldehyde for
15 minutes at room temperature and then stained with
crystal violet for 10 minutes at 37°C. Cells on the cover-
slips were mounted and imaged by microscopy. The
number of cells with platelets adhered was evaluated in
triplicate per × 40 magnification field.
Animal model
Male SD rats (180 ± 30 g) were maintained under clean
conventional conditions (24 ± 2°C, 12 h light/dark cycle)
and were allowed free access to water and food. The
DVT model was made as previously described [18]. Inbrief, the inferior vena cava (IVC) was exposed via a
midline incision in the abdomen followed by retraction
of intestines. The IVC was carefully dissected away
from the aorta for a distance of 2–3 mm immediately
inferior to the renal arteries. Upon injecting rapamycin
(500 ng/kg) or DMSO (control) into iliac vein, the IVC
was tied with a silk suture for 40 minutes. This proced-
ure thus created approximately a 100% cross-sectional
surface stenosis and a reduction of flow upstream of
the suture. Then the IVC was removed and fixed in
3.7% paraformaldehyde for subsequent Hematoxylin
and eosin staining and transmission electron micros-
copy (TEM) analysis.
All animal procedures were performed in accordance
with the National Institutes of Health Animal Care and
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the Animal Ethics Committee at the Beijing Institute of
Geriatrics.
Immunofluorescence staining
Cells cultured on gelatin-coated coverslips were washed
in PBS and fixed in 3.7% formaldehyde for 15 minutes at
room temperature. After blocked with 10% goat serum
for 15 minutes, the coverslips were incubated with pri-
mary antibody for 60 minutes and fluorescently labeled
secondary antibodies for 45 minutes at 37°C succes-
sively, and then washed extensively and mounted. Cells
were viewed by use of a Bio-Rad MRC 600 laser scan-
ning confocal microscope.
Electron microscopy
Cells or tissues were fixed in ice-cold 1.0% glutaralde-
hyde in 0.1 mol/L PBS and preserved at 4°C for further
processing. When processing resumed, the cells or tis-
sues were postfixed in 1% osmium tetroxide in the same
buffer, dehydrated in graded alcohols, embedded in Epon
812, sectioned with ultramicrotome (Leica, Germany),
and then stained with uranyl acetate and lead citrate.
The sections were examined with a transmission elec-
tron microscope (JEOL-1230, Japan).
Statistical analysis
All data were analyzed with SPSS statistics software
(Version 13.0, Chicago, IL, USA). Results were repre-
sented as mean ± standard deviation. Statistical analysis
was performed using the one-way analysis of variance
(ANOVA) or independent t-tests. A P-value less than
0.05 was considered statistically significant.
Discussion
By intravital microscopic examination, Iba et al. found
that in the venous occlusion rat model adhesion of leu-
kocytes to endothelium was the first event after clamp-
ing followed by minute leukocyte-platelet clusters.
These leukocyte-platelet aggregates move from venule
to vein and finally formed a venous thrombus [14]. Thus
it is important to identify what kind of factors affect the
adhesion between endothelium and leukocytes. One of
the possibilities, we speculated, is the remodeling of cell
membrane. Emerging evidence showed that the disturb-
ance of cellular membrane plays a pivotal role in throm-
bosis. For example, neutrophils interact with platelets
through membrane tethers, which procedure, the au-
thors believe, will be important in the process of inflam-
mation and thrombosis [19]. Data indicated that platelet
filopodia formation mediated by Cdc42 was required for
platelet aggregation [20]. And the development of mem-
brane tethers was essential for platelets aggregation and
concomitant thrombosis [21,22]. Another sample is thattumor vessels often exhibit ‘endothelial abnormaliza-
tion', characterized by a pseudostratified, hyperactive
endothelium with filopodialike protrusions. In parallel,
tumor vessels often show signs of thrombotic occlusion
[23]. Perhaps the rough surface of endothelium is one of
the reason for thrombosis.
Theoretically, the development of membrane ruffle/
tethers will increase the area for platelets to contact
with endothelium so that platelets have more oppor-
tunity to interact with endothelial cells. In our study,
platelets from the rapamycin-treated thrombolic rat
showed more filopodia (data not shown). In addition,
membrane ruffles in HUVECs and microvilli-like struc-
tures in the venous endothelium increased dramatically
under the condition of rapamycin incubation. It has
been found that endothelial microvilli are necessary
for lymphocyte-endothelium interaction [24], thus we
speculate that the enhanced membrane ruffles, micro-
villi (or filopodia) in both endothelium and platelets,
will strengthen the interaction between them and lead
to thrombosis.
Hypoxia and nutrient shortage, which are apt to
occur under the condition of stasis (eg. bed rest
>3 days, air travel >8 hours), can induce marked upreg-
ulation of autophagy in hemocytes and endothelial
cells [25,26]. The activated autophagy affected the rates
of thrombosis [27,28] of which the detailed mecha-
nisms are not clear. Recently, it was identified that
autophagy was essential for cytoskeleton remodeling
[8,9]. Researchers found that hemocyte-targeted RNAi
depletion of autophagy-related genes (Atg4, Atg6,
Atg7, Atg8a and Atg9) abolished the ability of hemo-
cytes to spread and extend F-actin protrusions. Mam-
malian macrophages disrupted for autophagy remained
predominantly circular in shape. In addition, live cell
imaging suggests that autophagy might contribute to
the cell protrusion attachment or extension [8]. More
and more evidence suggested that rapamycin promote
thrombosis (the mechanisms include rapamycin redu-
cing t-PA expression and inducing PAI-1/TF expres-
sion [10,11,27]). These conclusions were confirmed in
our experiment. In addition, we believe that membrane
remodeling induced by rapamycin is one of the respon-
sible mechanisms.Conclusions
In conclusion, we found that rapamycin stimulation in-
duced membrane remodeling in endothelial cells. And
the platelet-endothelial adhesion was enhanced in par-
allel. Further exploration suggested that autophagy in-
duced by rapamycin promoted membrane remodeling,
platelet-endothelial adhesion, and the concomitant
thrombosis.
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Additional file 1: Figure S1. (A) The time-course of effects of
rapamycin on thrombotic occlusion in rats. Data exhibited that
rapamycin promoted thrombotic occlusion with time. n = 5 in each
group. (B) HUVECs were cultured on the gelatin-coated coverslips.
Freshly isolated platelets, together with DMSO, were added to the
coverslip and incubated for 30 minutes. Cells were fixed and stained
with crystal violet. The coverslips were mounted and imaged by
microscopy. The time course of platelet-endothelial adhesion was
evaluated. Columns, means of three independent experiments; bars,
SD. (C). Platelets attached on the endothelium at the site of ruffles
(upper panel) and filopodialike protrusions (lower panel). HUVECs
were cultured on the coverslips and then PKH26 labeled platelets
were added into the medium. Cells were washed, fixed and stained
with (upper panel) or without (lower panel) anti-β-actin antibody and
the second fluorescent antibody. Then cells were analyzed with
microscopy (lower panel) or immunofluorescence microscopy
(upper panel).
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